IMPACT THERAP-B (07630) is scheduled to list on the Hong Kong stock exchange on Wednesday, May 13. At the time of writing, pre-market trading indicates a price of HK$44.06, representing a surge of 119.2% from its IPO price of HK$20.1. With each lot comprising 200 shares, the profit per lot, excluding transaction fees, amounts to HK$4,792.